Chronic myeloid leukemia data from India

Read More

Report of chronic myeloid leukemia from All India Institute of Medical Sciences, 1990-2010

Read More

Report of chronic myeloid leukemia in chronic phase from Tata Memorial Hospital, Mumbai, 2002-2008

Read More

Report of chronic myelogenous leukemia in chronic phase from, Asian Institute of Oncology, Mumbai, 2002-2010

Read More

Report of chronic myeloid leukemia from Indira Gandhi Institute of Medical Sciences, Regional Cancer Center, 2002-2009

Read More

Report of chronic myeloid leukemia in chronic phase from Eastern India, Institute of Hematology and Transfusion Medicine, Kolkata, 2001-2009

Read More

Report of chronic myeloid leukemia SMS Medical College Hospital, Jaipur

Read More

Report of chronic myeloid leukemia from SEAROC experience, Jaipur over a period of 9 years

Read More

Chronic myeloid leukemia treatment with Imatinib: An experience from a private tertiary care hospital

Read More

A short report on chronic myeloid leukemia from Post Graduate Institute of Medical Education and Research, Chandigarh

Read More

The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad

Read More

Report of patients with chronic myeloid leukemia, from hematology clinic, Ahmedabad, Gujarat 2000-2010 at 1 st myelostone meeting: Indian evidence of chronic myelogenous leukemia

Read More

Report of patients with chronic myeloid leukemia Kidwai Memorial Institute of Oncology, Bangalore over 15 years

Read More

Report of chronic myeloid leukemia in chronic phase from Ashirwad Hematology Centre, Mumbai, 2002-2009

Read More

Report of chronic myeloid leukemia in chronic phase from Omega Hospital and Indo-American Centre, Hyderabad, 2004-2010

Read More

Report of chronic myeloid leukemia in chronic phase from Cancer Institute (Women India Association), Chennai, 2002-2009

Read More

Report of chronic myeloid leukemia in chronic phase from Dr. Senthil Rajappa, 2002-2009

Read More

Epidemiological and clinical profile of patients with chronic myeloid leukemia at Health-Care Global, Bangalore Institute of Oncology

Read More

Imatinib mesylate resistance and mutations: An Indian experience

Read More

Kinase domain mutations and responses to dose escalation in chronic myeloid leukemia resistant to standard dose imatinib mesylate

Read More

Therapeutic drug monitoring for imatinib: Current status and Indian experience

Read More
//